DMPHF (Dermapharm Holding SE) Dividends Received


DMPHF Dermapharm Holding SE DMPHF
82 GF Score
Price $53.00
GF Value $45.76
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Dermapharm Holding SE Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

DMPHF
82GF Score
Dermapharm Holding SE DMPHF
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Dermapharm Holding SE (DMPHF) Overvalued in 2026?

Based on GuruFocus' analysis, Dermapharm Holding SE stock appears to be overvalued. The current stock price of $53.00 is trading 15.8% above its estimated GF Value™ of $45.76. GuruFocus considers Dermapharm Holding SE to be Significantly Overvalued.

Key valuation signals for DMPHF:

  • Dividends Received:
  • GF Value™: $45.76 vs. price of $53.00 (15.8% above fair value)
  • GF Score™: 82/100 with 10 warning signs

No single metric tells the full story. See the DMPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dermapharm Holding SE Business Description

Other Exchanges 0A5J:UKDMPd:UKDMP:Germany
Address Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.
82GF Score

Get the complete analysis for DMPHF

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$53.00
Price
$45.76
GF Value